Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Chemico-Biological Interactions

• Publication date

  2017-08-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cbi.2017.06.029PMID 28684144
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer

  2017cited by this paper
• Enhancement of cisplatin-induced colon cancer cells apoptosis by shikonin, a natural inducer of ROS in vitro and in vivo.

  2016cited by this paper
• Dihydromyricetin suppresses TNF-α-induced NF-κB activation and target gene expression

  2016cited by this paper
• Chronic Arsenic Exposure and Angiogenesis in Human Bronchial Epithelial Cells via the ROS/miR-199a-5p/HIF-1α/COX-2 Pathway

  2014cited by this paper
• Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.

  2013cited by this paper
• HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.

  2012cited by this paper
• Hypoxia-inducible factors in physiology and medicine.

  2012cited by this paper
• Shikonin extracted from medicinal Chinese herbs exerts anti-inflammatory effect via proteasome inhibition.

  2011cited by this paper
• Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy

  2010cited by this paper
• Suppression of Hypoxia-Inducible Factor 1α (HIF-1α) by Tirapazamine Is Dependent on eIF2α Phosphorylation Rather Than the mTORC1/4E-BP1 Pathway

  2010cited by this paper
• Role of ROS in ischemia-induced lung angiogenesis.

  2010cited by this paper
• Hypoxia-inducible factors in stem cells and cancer

  2009cited by this paper
• Regulation of oxygen homeostasis by hypoxia-inducible factor 1.

  2009cited by this paper
• Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition.

  2009cited by this paper
• Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises.

  2008cited by this paper
• Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.

  2008cited by this paper
• A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.

  2008cited by this paper
• The role of hypoxia-inducible factors in tumorigenesis

  2008cited by this paper
• Oxidative innate immune defenses by Nox/Duox family NADPH oxidases.

  2008cited by this paper
• Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions.

  2007cited by this paper
• Cytokines and hormones in the regulation of hypoxia inducible factor-1alpha (HIF-1alpha).

  2006cited by this paper
• Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer

  2006cited by this paper
• Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

  2006cited by this paper
• The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.

  2006cited by this paper
• Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.

  2005cited by this paper
• HIF-1alpha: a valid therapeutic target for tumor therapy.

  2004cited by this paper
• The role of hypoxia-induced factors in tumor progression.

  2004cited by this paper
• Free radicals and antioxidants in human health: current status and future prospects.

  2004cited by this paper
• Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosis1

  2003cited by this paper
• Targeting HIF-1 for cancer therapy

  2003cited by this paper
• Lactoperoxidase and hydrogen peroxide metabolism in the airway.

  2002cited by this paper
• Cellular pharmacology studies of shikonin derivatives

  2002cited by this paper
• p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD

  2001cited by this paper
• Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents.

  2001cited by this paper
• Induction of HIF–1α in response to hypoxia is instantaneous

  2001cited by this paper
• HIF-1: mediator of physiological and pathophysiological responses to hypoxia.

  2000cited by this paper

• Oral delivery of dextran-modified albumin nanoparticles loaded with shikonin for targeted therapy of colorectal cancer

  2025cites this paper
• CORDIAQUINONE B INDUCES CYTOTOXICITY AND OXIDATIVE STRESS-MEDIATED APOPTOSIS IN HUMAN COLORECTAL CANCER CELLS IN VITRO AND IN VIVO.

  2025cites this paper
• Shikonin as a therapeutic agent in renal cell carcinoma: insights from TEK-related causal association with glaucoma

  2025cites this paper
• Research progress of dual-targeting CDKs regulators for cancer therapy.

  2025cites this paper
• Systematic bioinformatics analysis reveals the role of shikonin in blocking colon cancer progression by identifying senescence-induced genes

  2024cites this paper
• Research progress on the structural and anti-colorectal malignant tumor properties of Shikonin.

  2024cites this paper
• Effect and mechanisms of shikonin on breast cancer cells in vitro and in vivo

  2024cites this paper
• Mechanism of Wenyang Shengji Ointment in treating diabetic wounds based on network pharmacology and animal experiments

  2024cites this paper
• Phytochemicals Target Multiple Metabolic Pathways in Cancer

  2023cites this paper
• Erianin: A phytoestrogen with therapeutic potential

  2023cites this paper
• Exploring Cancer Dependency Map genes and immune subtypes in colon cancer, in which TIGD1 contributes to colon cancer progression

  2023cites this paper
• Promising Nanomedicines of Shikonin for Cancer Therapy

  2023cites this paper
• Transcriptome analysis reveals the molecular basis of the response to acute hypoxic stress in blood clam Scapharca broughtonii

  2022cites this paper
• Ginsengenin derivatives synthesized from 20(R)-panaxotriol: Synthesis, characterization, and antitumor activity targeting HIF-1 pathway

  2022cites this paper
• Anti-Cancer Activity of Phytochemicals Targeting Hypoxia-Inducible Factor-1 Alpha

  2021cites this paper
• Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway.

  2021cites this paper
• Excisanin A suppresses proliferation by inhibiting hypoxiainducible factor-1α expression in human hepatocellular carcinoma cells

  2021cites this paper
• Synthesis and Evaluation of Chiral Rhodanine Derivatives Bearing Quinoxalinyl Imidazole Moiety as ALK5 Inhibitors.

  2021cites this paper
• Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer.

  2021cites this paper
• Shikonin suppresses colon cancer cell growth and exerts synergistic effects by regulating ADAM17 and the IL-6/STAT3 signaling pathway

  2021cites this paper
• Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation.

  2021cites this paper
• Anti-cancer Research on Arnebiae Radix-derived Naphthoquinone in Recent Five Years.

  2021cites this paper
• Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction

  2020cites this paper
• Modulation of dysregulated cancer metabolism by plant secondary metabolites: A mechanistic review.

  2020cites this paper
• Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity.

  2020cites this paper
• Integrated proteomics and metabolomics reveals the comprehensive characterization of antitumor mechanism underlying Shikonin on colon cancer patient-derived xenograft model

  2020cites this paper
• Synthesis, biological function and evaluation of Shikonin in cancer therapy.

  2019cites this paper
• Shikonin: A Review with a Focus on Anti-inflammatory and Anticancer Mechanisms

  2019influential citation
• Pharmacological Properties and Derivatives of Shikonin-A Review in Recent Years.

  2019cites this paper
• RETRACTED ARTICLE: Shikonin inhibits proliferation, migration, invasion and promotes apoptosis in NCI-N87 cells via inhibition of PI3K/AKT signal pathway

  2019cites this paper
• Dual Effects of Chinese Herbal Medicines on Angiogenesis in Cancer and Ischemic Stroke Treatments: Role of HIF-1 Network

  2019cites this paper
• Shikonin derivatives for cancer prevention and therapy.

  2019cites this paper
• Fraxinellone has anticancer activity in vivo by inhibiting programmed cell death‐ligand 1 expression by reducing hypoxia‐inducible factor‐1&agr; and STAT3

  2018cites this paper
• Rapid and sensitive determination of shikonin and its derivatives in the roots of Arnebia euchroma (Royle) Johnst using matrix solid-phase dispersion extraction and ultrahigh-performance liquid chromatography with photodiode array detector

  2018cites this paper
• Pro-Angiogenic and Anti-Angiogenic Effects of Small Molecules from Natural Products

  2018cites this paper
• Biosynthesis of Natural Products and Synthetic Biology of Antitumor Drugs

  2015cites this paper
• World Journal of Gastroenterology

  year unknowncites this paper